Literature DB >> 26924504

Decline in syphilis seroprevalence among females of reproductive age in Northern Cape Province, South Africa, 2003-2012: utility of laboratory-based information.

Ngormbu J Ballah1,2,3, Lazarus R Kuonza1,3, Gloria De Gita2, Alfred Musekiwa4, Seymour Williams4,5, Simbarashe Takuva2,6.   

Abstract

Strengthening current surveillance systems for syphilis is important to track and monitor disease burden. We used routinely collected laboratory information to generate surveillance estimates for syphilis trends among women of reproductive age (12-49 years) in the Northern Cape Province, a high syphilis burden region (2003 [8.6%] to 2011 [3.8%]) in South Africa. We extracted records meeting inclusion criteria from the National Health Laboratory Service electronic database for the period 2003-2012. A total of 286,024 women were included in the analysis. Syphilis seropositivity decreased between 2003 (5.7%) and 2012 (1.8%); p trend = 0.001, which was largely consistent with findings reported in the annual national syphilis and HIV survey from 2003 (8.6%) to 2011 (3.8%). Annually for the period from 2003 to 2012 there was an approximate 14% reduction in the prevalence ratio of syphilis seroprevalence (PR = 0.86, 95% CI = 0.85-0.87, p < 0.001). Three of five districts had significant decreases in syphilis seropositivity over this period. There were also declines in prevalence ratios for syphilis seropositivity for the various age groups for the period. This study shows that the national laboratory database in South Africa can be used as a complimentary surveillance tool to describe and understand trends in syphilis seroprevalence in South Africa.

Entities:  

Keywords:  Congenital syphilis; antenatal clinics; laboratory; prevalence; sexually transmitted infection; surveillance

Mesh:

Year:  2016        PMID: 26924504      PMCID: PMC5442386          DOI: 10.1177/0956462416636727

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  10 in total

1.  Declining syphilis prevalence in pregnant women in Nairobi since 1995: another success story in the STD field?

Authors:  M Temmerman; K Fonck; F Bashir; I Inion; J O Ndinya-Achola; J Bwayo; P Kirui; P Claeys; L Fransen
Journal:  Int J STD AIDS       Date:  1999-06       Impact factor: 1.359

2.  Treatment for syphilis in antenatal care: compliance with the three dose standard treatment regimen.

Authors:  S Mullick; M Beksinksa; S Msomi
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

3.  Declining syphilis prevalence among pregnant women in northern Botswana: an encouraging sign for the HIV epidemic?

Authors:  T L Creek; H Thuku; B Kolou; M Rahman; P H Kilmarx
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

4.  Integration of preventing mother-to-child transmission of HIV and syphilis testing and treatment in antenatal care services in the Northern Cape and Gauteng provinces, South Africa.

Authors:  Thu-Ha Dinh; Mary L Kamb; Veerle Msimang; Muptal Likibi; Thabo Molebatsi; Thurma Goldman; David A Lewis
Journal:  Sex Transm Dis       Date:  2013-11       Impact factor: 2.830

5.  Estimating incidence from age-specific prevalence for irreversible diseases with differential mortality.

Authors:  M J Podgor; M C Leske
Journal:  Stat Med       Date:  1986 Nov-Dec       Impact factor: 2.373

6.  The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa.

Authors:  Leigh F Johnson; Rob E Dorrington; Debbie Bradshaw; David J Coetzee
Journal:  Sex Reprod Healthc       Date:  2010-08-26

7.  Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia.

Authors:  Dara Potter; Robert L Goldenberg; Jennifer S Read; Jing Wang; Irving F Hoffman; Elmar Saathoff; George Kafulafula; Said Aboud; Francis E A Martinson; Maysoon Dahab; Sten H Vermund
Journal:  Sex Transm Dis       Date:  2006-10       Impact factor: 2.830

8.  A road map for the global elimination of congenital syphilis.

Authors:  Mary L Kamb; Lori M Newman; Patricia L Riley; Jennifer Mark; Sarah J Hawkes; Tasneem Malik; Nathalie Broutet
Journal:  Obstet Gynecol Int       Date:  2010-07-14

9.  Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa.

Authors:  G G Sherman; R R Lilian; S Bhardwaj; S Candy; P Barron
Journal:  S Afr Med J       Date:  2014-03

10.  Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data.

Authors:  Lori Newman; Mary Kamb; Sarah Hawkes; Gabriela Gomez; Lale Say; Armando Seuc; Nathalie Broutet
Journal:  PLoS Med       Date:  2013-02-26       Impact factor: 11.069

  10 in total
  5 in total

1.  An Update on the Global Epidemiology of Syphilis.

Authors:  Noah Kojima; Jeffrey D Klausner
Journal:  Curr Epidemiol Rep       Date:  2018-02-19

2.  Screening for Syphilis in Cases of Suspected Gonorrhea and Chlamydia Infections.

Authors:  Kumara V Nibhanipudi; Kenneth Cody
Journal:  Glob Pediatr Health       Date:  2017-07-12

3.  Evaluating patient data quality in South Africa's National Health Laboratory Service Data Warehouse, 2017-2020: implications for monitoring child health programmes.

Authors:  Lebohang Radebe; Ahmad Haeri Mazanderani; Gayle G Sherman
Journal:  BMC Public Health       Date:  2022-06-29       Impact factor: 4.135

4.  Global Disease Detection-Achievements in Applied Public Health Research, Capacity Building, and Public Health Diplomacy, 2001-2016.

Authors:  Carol Y Rao; Grace W Goryoka; Olga L Henao; Kevin R Clarke; Stephanie J Salyer; Joel M Montgomery
Journal:  Emerg Infect Dis       Date:  2017-11       Impact factor: 6.883

5.  Building Global Epidemiology and Response Capacity with Field Epidemiology Training Programs.

Authors:  Donna S Jones; Richard C Dicker; Robert E Fontaine; Amy L Boore; Jared O Omolo; Rana J Ashgar; Henry C Baggett
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.